tiprankstipranks
Trending News
More News >
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
US Market

Editas Medicine (EDIT) Technical Analysis

Compare
3,448 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Editas Medicine Inc’s (EDIT) Moving Averages Convergence Divergence (MACD) indicator is 0.15, suggesting Editas Medicine Inc is a Buy.
Editas Medicine Inc’s (EDIT) 20-Day exponential moving average is 2.05, while Editas Medicine Inc’s (EDIT) share price is $2.28, making it a Buy.
Editas Medicine Inc’s (EDIT) 50-Day exponential moving average is 1.82, while Editas Medicine Inc’s (EDIT) share price is $2.28, making it a Buy.

Editas Medicine (EDIT) Pivot Points

Jun 29, 2025, 07:31 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.91
1.99
2.06
2.14
2.20
2.28
2.35
Fibonacci
1.99
2.05
2.08
2.14
2.19
2.23
2.28
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Editas Medicine (EDIT) Moving Averages

Jun 29, 2025, 07:31 PM
Period
Simple
Exponential
MA5
2.19Buy
2.20Buy
MA10
2.18Buy
2.16Buy
MA20
2.04Buy
2.05Buy
MA50
1.73Buy
1.82Buy
MA100
1.60Buy
1.80Buy
MA200
2.03Buy
2.35Sell
Editas Medicine Inc’s (EDIT) 10-Day exponential moving average is 2.16, while Editas Medicine Inc’s (EDIT) share price is $2.28, making it a Buy.
Editas Medicine Inc’s (EDIT) 100-Day exponential moving average is 1.80, while Editas Medicine Inc’s (EDIT) share price is $2.28, making it a Buy.
Editas Medicine Inc’s (EDIT) stock price is $2.28 and Editas Medicine Inc’s (EDIT) 50-day simple moving average is 1.73, creating a Buy signal.
Editas Medicine Inc’s (EDIT) stock price is $2.28 and Editas Medicine Inc’s (EDIT) 100-day simple moving average is 1.60, creating a Buy signal.
Editas Medicine Inc’s (EDIT) stock price is $2.28 and Editas Medicine Inc’s (EDIT) 200-day simple moving average is 2.03, creating a Buy signal.

Editas Medicine (EDIT) Technical Indicators

Jun 29, 2025, 07:31 PM
Name
Value
Implied Action
RSI (14)
60.89
Neutral
STOCH (9,6)
42.55
Neutral
STOCHRSI (14)
53.49
Neutral
MACD (12,26)
0.15
Buy
ADX (14)
48.18
Neutral
Williams %R
-38.30
Buy
CCI (14)
85.12
Neutral
ATR (14)
0.21
-
Ultimate Oscillator
53.36
Neutral
ROC
19.37
Buy
Editas Medicine Inc’s (EDIT) Relative Strength Index (RSI) is 60.89, creating a Neutral signal.
Editas Medicine Inc’s (EDIT) Trend Strength Indicator (ADX) is 48.18, creating a Neutral signal.
Editas Medicine Inc’s (EDIT) Commodity Channel Index (CCI) is 85.12, creating a Neutral signal.
Editas Medicine Inc’s (EDIT) Price Rate of Change (ROC) is 19.37, creating a Buy signal.

FAQ

Is EDIT a Buy, Hold, or Sell?
Based on EDIT’s technical indicators, EDIT is a Strong Buy.
    What is EDIT’s RSI (14)?
    EDIT’s RSI (14) is 60.89, which suggests EDIT is a Neutral.
      What is EDIT’s MACD?
      EDIT’s MACD is 0.15, which suggests EDIT is a Buy.
        What is EDIT’s 5-day moving average?
        EDIT’s 5-day moving average is 2.19, which suggests EDIT is a Buy.
          What is EDIT’s 20-day moving average?
          EDIT 20-day moving average is 2.04, which suggests EDIT is a Buy.
            What is EDIT’s 50-day moving average?
            EDIT’s 50-day moving average is 1.73, which suggests EDIT is a Buy.
              What is EDIT’s 200-day moving average?
              EDIT’s 200-day moving average is 2.03, which suggests EDIT is a Buy.
                What is EDIT’s Williams % R (14)?
                EDIT’s Williams % R (14) is -38.30, which suggests EDIT is a Buy.
                  What is EDIT’s CCI (14)?
                  EDIT’s CCI (14) is 85.12, which suggests EDIT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis